Ignite Creation Date:
2025-12-24 @ 7:12 PM
Ignite Modification Date:
2026-01-24 @ 10:00 PM
Study NCT ID:
NCT02142803
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-11-13
First Post:
2014-05-16
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-05-20
Start Date Type:
ACTUAL
Primary Completion Date:
2020-12-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-10-16
Completion Date Type:
ESTIMATED
First Submit Date:
2014-05-16
First Submit QC Date:
None
Study First Post Date:
2014-05-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2022-11-21
Results First Submit QC Date:
None
Results First Post Date:
2023-10-04
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-29
Last Update Post Date:
2025-11-13
Last Update Post Date Type:
ESTIMATED